Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of METABASIS THERAPEUTICS, INC. patents

Patents where

Current Assignee

Name

‌

METABASIS THERAPEUTICS, INC.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7303739 Prodrugs for liver specific drug delivery	Patent 7303739 was granted and assigned to METABASIS THERAPEUTICS, INC. on December, 2007 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	7303739	December 4, 2007
‌ US Patent 7514419 Phosphorus-containing thyromimetics	Patent 7514419 was granted and assigned to METABASIS THERAPEUTICS, INC. on April, 2009 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	7514419	April 7, 2009
‌ US Patent 7829552 Phosphorus-containing thyromimetics	Patent 7829552 was granted and assigned to METABASIS THERAPEUTICS, INC. on November, 2010 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	7829552	November 9, 2010
‌ US Patent 10130643 Thyromimetics for the treatment of fatty liver diseases	Patent 10130643 was granted and assigned to METABASIS THERAPEUTICS, INC. on November, 2018 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	10130643	November 20, 2018
‌ US Patent 10925885 Thyromimetics for the treatment of fatty liver diseases	Patent 10925885 was granted and assigned to METABASIS THERAPEUTICS, INC. on February, 2021 by the United States Patent and Trademark Office.	‌ METABASIS THERAPEUTICS, INC.	‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	10925885	February 23, 2021
‌ US Patent 8063025 Nucleoside prodrugs and uses thereof	Patent 8063025 was granted and assigned to METABASIS THERAPEUTICS, INC. on November, 2011 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	8063025	November 22, 2011
‌ US Patent 11352321 Glucagon antagonists	Patent 11352321 was granted and assigned to METABASIS THERAPEUTICS, INC. on June, 2022 by the United States Patent and Trademark Office.	‌ METABASIS THERAPEUTICS, INC.	‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	11352321	June 7, 2022
‌ US Patent 9701626 Antagonists of the glucagon receptor	Patent 9701626 was granted and assigned to METABASIS THERAPEUTICS, INC. on July, 2017 by the United States Patent and Trademark Office.	‌ METABASIS THERAPEUTICS, INC.	‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	9701626	July 11, 2017
‌ US Patent 8710236 Antagonists of the glucagon receptor	Patent 8710236 was granted and assigned to METABASIS THERAPEUTICS, INC. on April, 2014 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	8710236	April 29, 2014
‌ US Patent 7582758 Lewis acid mediated synthesis of cyclic esters	Patent 7582758 was granted and assigned to METABASIS THERAPEUTICS, INC. on September, 2009 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	7582758	September 1, 2009
‌ US Patent 6946115 Prodrugs for phosphorus-containing compounds	Patent 6946115 was granted and assigned to METABASIS THERAPEUTICS, INC. on September, 2005 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	6946115	September 20, 2005
‌ US Patent 7666855 2′-C-methyl nucleoside derivatives	Patent 7666855 was granted and assigned to METABASIS THERAPEUTICS, INC. on February, 2010 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	7666855	February 23, 2010
‌ US Patent 9340566 Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof	Patent 9340566 was granted and assigned to METABASIS THERAPEUTICS, INC. on May, 2016 by the United States Patent and Trademark Office.	‌ METABASIS THERAPEUTICS, INC.	‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	9340566	May 17, 2016
‌ US Patent 9783494 Glucagon antagonists	Patent 9783494 was granted and assigned to METABASIS THERAPEUTICS, INC. on October, 2017 by the United States Patent and Trademark Office.	‌ METABASIS THERAPEUTICS, INC.	‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	9783494	October 10, 2017
‌ US Patent 10221130 Glucagon antagonists	Patent 10221130 was granted and assigned to METABASIS THERAPEUTICS, INC. on March, 2019 by the United States Patent and Trademark Office.	‌ METABASIS THERAPEUTICS, INC.	‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	10221130	March 5, 2019
‌ US Patent 7151092 Cytarabine monophosphate prodrugs	Patent 7151092 was granted and assigned to METABASIS THERAPEUTICS, INC. on December, 2006 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	7151092	December 19, 2006
‌ US Patent 8962618 Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof	Patent 8962618 was granted and assigned to METABASIS THERAPEUTICS, INC. on February, 2015 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	8962618	February 24, 2015
‌ US Patent 7193081 Process for preparation of cyclic prodrugs of PMEA and PMPA	Patent 7193081 was granted and assigned to METABASIS THERAPEUTICS, INC. on March, 2007 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	7193081	March 20, 2007
‌ US Patent 8940927 Activators of glucokinase	Patent 8940927 was granted and assigned to METABASIS THERAPEUTICS, INC. on January, 2015 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	8940927	January 27, 2015
‌ US Patent 7553826 Cytarabine monophosphate prodrugs	Patent 7553826 was granted and assigned to METABASIS THERAPEUTICS, INC. on June, 2009 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	7553826	June 30, 2009
‌ US Patent 7205404 Phosphorus-containing prodrugs	Patent 7205404 was granted and assigned to METABASIS THERAPEUTICS, INC. on April, 2007 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	7205404	April 17, 2007
‌ US Patent 7498320 Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs	Patent 7498320 was granted and assigned to METABASIS THERAPEUTICS, INC. on March, 2009 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	7498320	March 3, 2009
‌ US Patent 7148349 Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs	Patent 7148349 was granted and assigned to METABASIS THERAPEUTICS, INC. on December, 2006 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	7148349	December 12, 2006
‌ US Patent 10174062 Activators of glucokinase	Patent 10174062 was granted and assigned to METABASIS THERAPEUTICS, INC. on January, 2019 by the United States Patent and Trademark Office.	‌ METABASIS THERAPEUTICS, INC.	‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	10174062	January 8, 2019
‌ US Patent 7351399 Prodrugs for phosphorus-containing compounds	Patent 7351399 was granted and assigned to METABASIS THERAPEUTICS, INC. on April, 2008 by the United States Patent and Trademark Office.		‌ METABASIS THERAPEUTICS, INC.	United States Patent and Trademark Office	7351399	April 1, 2008

Results per page:

46 results

0 selected

46 results

0 selected